BiotechTube

ALTO-100 + Placebo

Phase 2Recruiting
0 views this week 0 watching💤 Quiet
Interest: 36/100
36
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bipolar Disorder I or II With a Major Depressive Episode

Conditions

Bipolar Disorder I or II With a Major Depressive Episode

Trial Timeline

Oct 2, 2024 → Oct 1, 2026

NCT ID
NCT06656416

About ALTO-100 + Placebo

ALTO-100 + Placebo is a phase 2 stage product being developed by Alto Neuroscience for Bipolar Disorder I or II With a Major Depressive Episode. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06656416. Target conditions include Bipolar Disorder I or II With a Major Depressive Episode.

What happened to similar drugs?

20 of 20 similar drugs in Bipolar Disorder I or II With a Major Depressive Episode were approved

Approved (20) Terminated (3) Active (0)
✅Olanzapine + PlaceboEli LillyApproved
✅OlanzapineEli LillyApproved
✅OlanzapineEli LillyApproved
✅olanzapine + divalproex sodium + placeboEli LillyApproved
✅olanzapine + risperidoneEli LillyApproved
✅Topiramate + PlaceboEli LillyApproved
✅Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved

Hype Score Breakdown

Clinical
12
Activity
15
Company
9
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT06656416Phase 2Recruiting
NCT05712187Phase 2Completed

Competing Products

20 competing products in Bipolar Disorder I or II With a Major Depressive Episode

See all competitors
ProductCompanyStageHype Score
OlanzapineEli LillyPhase 3
32
Valproate + Lithium + Risperidone + OlanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyApproved
43
FK949EAstellas PharmaPhase 3
40
FK949EAstellas PharmaPhase 3
40
FK949E + PlaceboAstellas PharmaPhase 2/3
38
Escitalopram + Bupropion XLLupin LimitedPhase 3
32
OlanzapineEli LillyApproved
43
Olanzapine Hydrochloride + Lithium CarbonateEli LillyPhase 3
40
olanzapine + lithium + valproate + carbamazepineEli LillyPhase 3
40
OlanzapineEli LillyApproved
43
OlanzapineEli LillyPhase 3
40
LY2979165 + PlaceboEli LillyPhase 1
29
olanzapine + divalproex sodium + placeboEli LillyApproved
43
olanzapine + risperidoneEli LillyApproved
43
LY2979165 + placeboEli LillyPhase 1
29
Topiramate + PlaceboEli LillyApproved
43
olanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyPhase 3
40
Brenipatide + PlaceboEli LillyPhase 2
42